94756-4SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1Active
Term Description
Qualitative detection of nucleic acids within the N gene of SARS coronavirus 2 (SARS-CoV-2) in respiratory specimens by nucleic acid amplification with probe-based detection using the N1 primer-probe set developed by the Centers for Disease Control and Prevention (CDC). [CDC:coronavirus/COVID-19/lab/]
Source: Regenstrief LOINC
Part Description
LP417599-0 SARS coronavirus 2 N gene
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC:coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance]
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 N gene
- Property
- PrThr
- Time
- Pt
- System
- Respiratory
- Scale
- Ord
- Method
- Probe.amp.tar.CDC primer-probe set N1
Additional Names
- Short Name
- SARS-CoV-2 N gene Resp Ql NAA N1
- Display Name
- SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 Ql (Resp)
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19) N gene, Respiratory
Ask At Order Entry
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
81959-9 | Public health laboratory ask at order entry panel | |||
Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
Indent86952-9 | Preliminary testing done Specimen | |||
Indent86953-7 | Preliminary testing result Specimen | |||
Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
Indent95418-0 | Whether patient is employed in a healthcare setting | |||
Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
Indent11368-8 | Illness or injury onset date and time | C | ||
Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
Indent95421-4 | Whether patient resides in a congregate care setting | |||
Indent82810-3 | Pregnancy status | C | ||
Indent30525-0 | Age | a |
Example Answer List LL744-4
Source: Regenstrief Institute
Answer | Code | Score | Answer ID |
---|---|---|---|
Detected | LA11882-0 | ||
Not detected | LA11883-8 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Observation
Reference Information
Type | Source | Reference |
---|---|---|
Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Member of these Panels
LOINC | Long Common Name |
---|---|
96094-8 | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection |
94531-1 | SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection |
Member of these Groups
LG51004-6 | SARS coronavirus 2 N gene| |
LG51017-8 | SARSCoV2 detection |
LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 N 基因:
存在情况或阈值: 时间点: 呼吸道: 序数型: 探针法.基因扩增.靶向.CDC 引物-探针组 N1 - nl-NLDutch (Netherlands)
- SARS-CoV-2 N-gen:
aanwezigheid: moment: luchtwegen: ordinaal: PCR met CDC primer-probe set N1 - fr-FRFrench (France)
- Coronavirus SARS-CoV-2 gène N:
Présence/Seuil: Ponctuel: Respiratoire: Qualitatif: PCR amplification de cible N1 - de-DEGerman (Germany)
- SARS-Coronavirus 2 N-Gen:
Nachweis oder Schwellenwert: Zeitpunkt: Probenmaterial aus dem Respirationstrakt: Ordinal: Zielfragmentamplifikation mit Sondendetektion mit CDC Primer-Sondenset N1 - it-ITItalian (Italy)
- SARS coronavirus 2, gene N:
PrThr: Pt: Respiratorio: Ord: Sonda.amp.tar.CDC set primer-sonda N1 - es-MXSpanish (Mexico)
- Gen del coronavirus 2 N del SARS:
Presencia o umbral: Punto temporal: Espécimen respiratorio: Ordinal: Amplificación de ácido nucleico utilizando el conjunto de cebadores y sondas de los Centros para el Control y la Prevención de Enfermedades N1 - es-ESSpanish (Spain)
- Gen N de SARS-CoV-2 (COVID-19):
PrThr: Punto temporal: Respiratorio: Ord: Amplificación de ácido nucleico utilizando el conjunto de cebadores y sondas N1 de los Centros para el Control y la Prevención de Enfermedades
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94756-4
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright